Relmada Therapeutics RLMD
NASDAQ RLMD
$4.27 +0.13 (+3.14%)
At close: Nov 10, 2026 · 4:00 PM EST

Relmada Therapeutics (RLMD) EBT (2012 - 2026)

Updated

Analysis

Relmada Therapeutics (RLMD) EBT (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 34.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 4.83 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 2.80 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.69 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.06 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 3.39 Bn
10 Relmada Therapeutics 473.10 Mn -85.48 Mn - -12.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.71 Mn
Mar 31, 2026 -18.50 Mn
Dec 31, 2025 -19.95 Mn
Sep 30, 2025 -10.08 Mn
Jun 30, 2025 -9.90 Mn
Mar 31, 2025 -17.78 Mn
Dec 31, 2024 -18.42 Mn
Sep 30, 2024 -22.15 Mn
Jun 30, 2024 -17.86 Mn
Mar 31, 2024 -21.93 Mn
Dec 31, 2023 -25.57 Mn
Sep 30, 2023 -21.37 Mn
Jun 30, 2023 -24.66 Mn
Mar 31, 2023 -26.95 Mn
Dec 31, 2022 -38.70 Mn
Sep 30, 2022 -38.74 Mn
Jun 30, 2022 -45.51 Mn
Mar 31, 2022 -38.30 Mn
Dec 31, 2021 -34.18 Mn
Sep 30, 2021 -42.65 Mn
API Access

Relmada Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=RLMD&period=max&api_key=YOUR_API_KEY